Stock Chart

STVN

$15.73 +0.96%
Score: 51.7 HOLD
1Y Target $14.41 -8.4%
i
1Y Price Target

This target is derived from long-term trendline analysis and projected growth.

Note: Targets are based on the assumption that the current primary trend continues. They should be used as reference points, not guarantees.

Target may adjust dynamically as the stock trend reverses or accelerates.
LEAPs: SELL $25
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $25
Premium: $1.85
Expiry: Mar 20, 2026
Target: $23
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $11.52 - $12.45 STRONG_DOWNTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.84
Vol: 1.76x (vs SPY: 1.8x | vs QQQ: 1.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About STVN - Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology …

Key Statistics

Market Cap $4B
P/E Ratio 25.97
Dividend Yield 0.00%

This STVN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track STVN's price movements with trendlines, gamma walls, and key support/resistance levels.